公告提醒:爱必信所有产品和服务仅用于科学研究,不用于临床应用及其他用途提供产品和服务(也不为任何个人提供产品和服务)! YZ剂描述: 产品名称:Gardiquimod trifluoroacetate 产品别名:见爱必信官网 英文别名:Gardiquimod trifluoroacetate 靶点:TLR7, HIV-1 reverse transcriptase CAS:1159840-61-5 纯度:98% 外观:见爱必信官网 保存方法:store at -20℃ for one year(Powder) 描述:Gardiquimod trifluoroacetate is a specific TLR7 agonist which can also inhibit HIV-1 reverse transcriptase. 溶解性: In Vitro: DMSO : 100 mg/mL (184.69 mM; Need ultrasonic) H2O : 25 mg/mL (46.17 mM; Need ultrasonic) Preparing Stock Solutions ConcentrationSolventMass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 1.8469 mL | 9.2346 mL | 18.4693 mL | 5 mM | 0.3694 mL | 1.8469 mL | 3.6939 mL | 10 mM | 0.1847 mL | 0.9235 mL | 1.8469 mL |
*请根据产品在不同溶剂中的溶解度,选择合适的溶剂配制储备液,并请注意储备液的保存方式和期限。 In Vivo: 请根据您的实验动物和给YF式选择适当的溶解方案,配制前请先配制澄清的储备液,再依次添加助溶剂(为保证实验结果的可靠性,体内实验的工作 液,建议您现用现配,当天使用;澄清的储备液可以根据储存条件,适当保存;以下溶剂前的百分比是指该溶剂在您配制终溶液中的体积占比): 1. 请依序添加每种溶剂: 10% DMSO 40% PEG300 5% Tween-80 45% saline Solubility: ≥ 2.5 mg/mL (4.62 mM); Clear solution 2. 请依序添加每种溶剂: 10% DMSO 90% (20% SBE-β-CD in saline) Solubility: ≥ 2.5 mg/mL (4.62 mM); Clear solution 3. 请依序添加每种溶剂: 10% DMSO 90% corn oil Solubility: ≥ 2.5 mg/mL (4.62 mM); Clear solution
* 体外研究: Levels of HIV-1 DNA measured by real-time PCR are significantly lower in Gardiquimod trifluoroacetate-treated cells compare to untreated controls on day 9 postinfection. Significantly lower levels of HIV-1 DNA and HIV-1 p24 are observed in Gardiquimod trifluoroacetate-treated and HIV-1-exposed macrophages cocultured with activated PBMCs. Gardiquimod trifluoroacetate significantly increases IFN-α mRNA levels 80-, 20-, and 35-fold above the level of detection at 2, 4, and 6 h posttreatment, respectively. The results show that treatment with Gardiquimod trifluoroacetate results in significant increases in expression of CD69 on T, NK and natural killer T (NKT) cells. It is also found that Gardiquimod trifluoroacetate stimulation increases mRNA expression of IL-12 p40 in RAW264.7 cells. Furthermore, Gardiquimod trifluoroacetate induces augmented secretion of IL-12 p70 into culture supernatant 48 and 72 h after treatment. 体内研究:Levels of HIV-1 DNA measured by real-time PCR are significantly lower in Gardiquimod trifluoroacetate-treated cells compare to untreated controls on day 9 postinfection. Significantly lower levels of HIV-1 DNA and HIV-1 p24 are observed in Gardiquimod trifluoroacetate-treated and HIV-1-exposed macrophages cocultured with activated PBMCs. Gardiquimod trifluoroacetate significantly increases IFN-α mRNA levels 80-, 20-, and 35-fold above the level of detection at 2, 4, and 6 h posttreatment, respectively. The results show that treatment with Gardiquimod trifluoroacetate results in significant increases in expression of CD69 on T, NK and natural killer T (NKT) cells. It is also found that Gardiquimod trifluoroacetate stimulation increases mRNA expression of IL-12 p40 in RAW264.7 cells. Furthermore, Gardiquimod trifluoroacetate induces augmented secretion of IL-12 p70 into culture supernatant 48 and 72 h after treatment. 产品信息订购: 产品货号 | 产品名称 | 规格 | 价格 | 大包装及货期 | abs820262 | Gardiquimod trifluoroacetate | 5mg | 660 | 立即咨询 | 产品更多信息请进入爱必信网站咨询 |